Latest
19:11
[ CGII HLDGS (01940.HK): Completion of Loan Assignment ] NewTimeSpace News: CGII HLDGS announced on June 17 that the Company entered into a supplemental deed with the assignee and extended the completion date to June 17. The assignee has fully settled the consideration, and the loan assignment has been completed.
Tag:
CGII HLDGS01940.HK
19:00
[ Fosun Pharma (02196.HK): Controlled Subsidiary’s HLX3902 Injection Obtains Clinical Trial Approval ] NewTimeSpace News: Fosun Pharma announced on June 17 that its controlled subsidiary Henlius has received approval from the National Medical Products Administration (NMPA) to conduct Phase I clinical trials for its self-developed HLX3902 Injection (STEAP1×CD3×CD28 trispecific antibody) in the treatment of metastatic castration-resistant prostate cancer and other advanced solid tumors.
Tag:
FOSUN PHARMA02196.HK
18:57
[ Xunhe Group (01591.HK): Expected Annual Loss to Widen to HK$13 Million – HK$16 Million ] NewTimeSpace News: Xunhe Group issued a profit warning on June 17, forecasting a net loss of approximately HK$13 million to HK$16 million for the year ended March 31, 2026, representing a substantial widening from the previous year’s net loss of around HK$5.7 million.
Tag:
Xunhe Group01591.HK